Clinical application of Albumin-Bilirubin (ALBI) score: The current status. Issue 3 (June 2020)

• Record Type: Journal Article
• Authors: Deng, Min; Ng, Sally Wing Yan; Cheung, Siu Tim; Chong, Charing Ching Ning
• Is Part Of: Surgeon. Volume 18:Issue 3(2020)
• Page Start: 178
• Page End: 186
• Publication Date: 2020-06
• Subjects: ALBI -- Prognosis -- Survival -- Liver function; Surgery -- Periodicals; Surgery -- Periodicals; Surgical Procedures, Operative -- Periodicals; 617
• DOI: 10.1016/j.surge.2019.09.002
• Languages: English
• ISSNs: 1479-666X

Abstract

Abstract: Prognosis of patients that have undergone liver resection can be predicted preoperatively. Albumin-Bilirubin (ALBI) is a useful score to evaluate liver function objectively. This score is simple to use, uses objective parameters, and can stratify patients into grades. In combination with other liver cancer scores, the prognosis and survival of patients can be evaluated with more accuracy. Current literatures supporting the use of the ALBI score relating to prognosis of post hepatectomy, radiofrequency ablation (RFA), transarterial chemoembolization (TACE), radiotherapy and systemic therapy are available. Therefore, ALBI score is worthy of clinical application. The following is a review of the current literatures on the ALBI score. Highlights: Albumin-Bilirubin (ALBI) is a useful score to evaluate liver function objectively. ALBI score is simple to use, uses objective parameters, and can stratify patients into grades. In combination with other liver cancer scores, the prognosis and survival of patients can be evaluated with more accuracy. ALBI score is worthy of clinical application.